| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 04/20/2010 | US7700766 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 04/01/2010 | WO2010014836A3 Tgr5 modulators and methods of use thereof |
| 03/31/2010 | CN101687904A Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 03/24/2010 | CN101679476A 23-substituted bile acids as TGR5 modulators and methods of use thereof |
| 03/11/2010 | WO2010003391A3 Anionic pregnane compounds, method for their producing and use of them |
| 03/09/2010 | CA2425572C Process and intermediates for the production of 7-substituted antiestrogens |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/11/2010 | WO2010016931A2 Polymorphs of fluticasone furoate and process for preparation thereof |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 02/04/2010 | WO2010014836A2 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | CA2732323A1 Tgr5 modulators and methods of use thereof |
| 01/13/2010 | EP1594884B1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 12/31/2009 | US20090325918 Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action |
| 12/08/2009 | US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 11/25/2009 | EP2121723A2 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 11/17/2009 | CA2406847C Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols |
| 11/05/2009 | US20090275543 Modified Glycosaminoglycans, Pharmaceutical Compositions and Methods for Oral Delivery Thereof |
| 11/04/2009 | EP2112995A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 10/28/2009 | EP1474436B1 Process for the production of fluticasone propionate, in particular of polymorphic form 1 |
| 10/15/2009 | WO2009059765A3 Process for the preparation of drospirenone |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/17/2009 | WO2009085880A3 C-21 thioethers as glucocorticoid receptor agonists |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/03/2009 | US20090221841 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 08/19/2009 | EP2088865A2 Guggulphospholipid methods and compositions |
| 07/30/2009 | WO2009013310A3 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl)nonyl]estra-1,3,5(10)-triene-3,17-beta-diol |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/09/2009 | WO2009085880A2 C-21 thioethers as glucocorticoid receptor agonists |
| 07/09/2009 | US20090177001 Novel process and intermediates |
| 07/09/2009 | CA2710240A1 C-21 thioethers as glucocorticoid receptor agonists |
| 06/25/2009 | WO2009043577A3 Contraceptive 19-nor progesterones |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP1575981B1 Angiogenic acting tri-sulphate steroids and uses thereof |
| 05/14/2009 | WO2009059765A2 Process for the preparation of drospirenone |
| 05/14/2009 | US20090124585 Novel Crystalline Pharmaceutical Product |
| 05/12/2009 | US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/09/2009 | WO2009043577A2 Contraceptive 19-nor progesterones |
| 04/08/2009 | EP2044099A2 Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 04/08/2009 | EP2044098A2 Process for the preparation of 6-alpha ,9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl ester |
| 04/02/2009 | WO2009039700A1 Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentvlsulphinvl) nonvllestra-l,3,5-(10)- triene-3,17-beta-diol |
| 04/02/2009 | US20090087389 Dehydroepiandrosterone sulfate dihydrate inhalation compositions and methods |
| 04/01/2009 | EP2040713A2 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/11/2009 | EP2033966A2 Movel photoacid generators, resist compositons, and patterning processes |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/11/2009 | CN101384610A Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/25/2009 | EP2027140A1 Industrial process for the synthesis of 17 alpha -acetoxy-11 beta -[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 01/29/2009 | WO2008100769A3 Process for selective sulfation of aromatic hydroxyl groups |
| 01/20/2009 | CA2400919C Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/24/2008 | EP2004667A2 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 12/09/2008 | CA2462998C Novel estrogenic compounds |
| 12/03/2008 | EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 11/25/2008 | US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract |
| 11/13/2008 | WO2008115069A3 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 10/15/2008 | EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 10/09/2008 | WO2007099548A3 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 09/25/2008 | WO2008091540A3 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 09/23/2008 | US7427610 e.g. 17 beta -Difluoromethyl-2-methoxy-estra-1,3,5(10)-trien-3-yl sulfamate; tubulin polymerization inhibitor; breast, prostate, colon, non-small-cell-lung cancer and primary dermal microvascular endothelial cell proliferation |
| 09/18/2008 | WO2008109936A1 Steroidal compounds |
| 09/02/2008 | US7419972 e.g. 3-Hydroxy-2-phenylethinyl-estra-1,3,5(10)-trien-17-one 19; anticarcinogenic, antitumor agent; hormone-dependent tumor disease of a male/female reproductive gland or endometriosis; estrogen-dependent diseases |
| 08/27/2008 | EP1594886B1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 08/13/2008 | EP1955700A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/06/2008 | EP1328538B1 Process and intermediates for the production of 7-substituted antiestrogens |
| 08/05/2008 | CA2272721C Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 07/31/2008 | WO2008091540A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 07/31/2008 | CA2676417A1 Tgr5 modulators and methods of use thereof |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/18/2008 | EP1301526B1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 06/18/2008 | CN100395259C Steroid derivatives |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 05/21/2008 | EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/13/2008 | US7371741 Angiogenesis inhibitor |
| 05/07/2008 | EP1918295A2 Process and Intermediates |
| 05/02/2008 | WO2007144363A3 Process for the preparation of 6-alpha, 9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-s-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl |
| 04/30/2008 | EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/30/2008 | CN100384866C Process for prepn. of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for epoxidation of olifinic double bonds |
| 04/16/2008 | EP1911741A1 Method for the preparation of fluticasone propionate |
| 03/18/2008 | US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 03/11/2008 | US7342004 Superoxide dismutase inhibitors |
| 02/28/2008 | WO2007144668A3 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 02/20/2008 | CN100369927C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/31/2008 | US20080027237 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/03/2008 | CA2656320A1 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 12/27/2007 | US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/21/2007 | WO2007144674A1 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS |
| 12/21/2007 | WO2007144668A2 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |